Morgan Stanley analysts say a trial to test whether Novo Nordisk’s blockbuster weight-loss drug also will work against ...

Key Takeaways Morgan Stanley downgraded and cut the price target on Novo Nordisk stock, citing GLP-1 concerns.The analysts also raised doubts about the effectiveness of the drugmaker's experimental ...

Morgan Stanley Is Confident About XPeng’s Prospects. Hsiao expects XPeng to deliver solid monthly sales in 2025 and continue to expand in 2026, driven by the successful launches ...

One analyst thinks this surging tech stock can soar even higher.

Investing.com -- Morgan Stanley lifted its price target on Alibaba to $200 from $165, citing accelerating growth in its cloud ...

Michelin was kept at Overweight, with Morgan Stanley expecting margins to expand between 2026 and 2028 as the French group shifts further toward larger and premium tyres. There is also a dividend ...

Financial services giant Morgan Stanley says that the US economy has incredible upward momentum and that a stock market ...

Banking giant Morgan Stanley believes the equity market can sustain its rallies to new all-time highs if several favorable ...

The stock's fall snapped a five-day winning streak.

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good ...

Morgan Stanley raised the IndusInd Bank price target to Rs 785 from Rs 750. The new target implies a 9% potential upside for the stock. Analysts said valuation looks attractive as the stock has fallen ...

Morgan Stanley has recently revealed its plans to integrate cryptocurrency trading directly into its E*Trade brokerage ...